No abstract available
MeSH terms
-
Atorvastatin
-
Cardiovascular Diseases / economics
-
Cardiovascular Diseases / epidemiology*
-
Cardiovascular Diseases / mortality
-
Cardiovascular Diseases / prevention & control*
-
Cost-Benefit Analysis
-
Drug Costs
-
Heptanoic Acids / administration & dosage
-
Humans
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage*
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / economics*
-
Patient Participation
-
Practice Guidelines as Topic
-
Primary Prevention / standards
-
Pyrroles / administration & dosage
-
Risk Assessment
-
Risk Factors
-
Risk Reduction Behavior*
-
Secondary Prevention / standards
-
United Kingdom / epidemiology
Substances
-
Heptanoic Acids
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors
-
Pyrroles
-
Atorvastatin